The Europe Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 19.9% CAGR during the forecast period (2021-2027).
Automated and closed systems provide improved cell management capabilities and decrease the chances of errors at the time of bioprocessing. Cell therapy is widely used in numerous kinds of disorders, particularly in cancer & nervous disorders. Some other applications of cell therapy include diabetes mellitus, genetic disorders, diseases of bones and joints, cardiac disorders (myocardial infarction and heart failure), and wounds of the skin & soft tissues.
Along with that, cell therapy is utilized in the development of regenerative medicines that are an interdisciplinary domain focused on maintenance, enhancement, or restoration of cell, tissue, organ function with the help of procedures majorly associated with cell therapy.
The supportive government reimbursement policies across various nations of the region and the growing demand for advanced cell therapies and automated systems over the forecast period. Moreover, the strong facility network and workforce across various European countries is estimated to spur the growth of the regional market in the coming years. Cell therapies are widely utilized in the treatment of chronic diseases like cancer, and the increasing cases of chronic diseases would further surge the growth of the regional automated and closed cell therapy processing systems market during the forecast period.
The Germany market dominated the Europe Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $143.5 million by 2027. The UK market is experiencing a CAGR of 19% during (2021 - 2027). Additionally, the France market would expect a CAGR of 22.1% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Automated and Closed Cell Therapy Processing Systems Market Size will Hit $37.9 billion by 2027, at a CAGR of 32.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Separation
- Expansion
- Apheresis
- Fill-Finish
- Cryopreservation
By Workflow
- Stem Cell Therapy
- Non-Stem Cell Therapy
By Scale
- Pre-commercial/R&D Scale
- Commercial Scale
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Automated And Closed Cell Therapy Processing Systems Market, by workflow
1.4.2 Europe Automated And Closed Cell Therapy Processing Systems Market, by type
1.4.3 Europe Automated And Closed Cell Therapy Processing Systems Market, by Scale
1.4.4 Europe Automated And Closed Cell Therapy Processing Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
Chapter 4. Europe Automated and Closed Cell Therapy Processing Systems Market by Type
4.1 Europe Non-Stem Cell Therapy Market by Country
4.2 Europe Stem Cell Therapy Market by Country
Chapter 5. Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow
5.1 Europe Expansion Market by Country
5.2 Europe Separation Market by Country
5.3 Europe Apheresis Market by Country
5.4 Europe Cryopreservation Market by Country
5.5 Europe Fill- Finish Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Automated and Closed Cell Therapy Processing Systems Market by Scale
6.1 Europe Pre-commercial/ R&D Scale Market by Country
6.2 Europe Commercial Scale Market by Country
Chapter 7. Europe Automated and Closed Cell Therapy Processing Systems Market by Country
7.1 Germany Automated and Closed Cell Therapy Processing Systems Market
7.1.1 Germany Automated and Closed Cell Therapy Processing Systems Market by Type
7.1.2 Germany Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.1.3 Germany Automated and Closed Cell Therapy Processing Systems Market by Scale
7.2 UK Automated and Closed Cell Therapy Processing Systems Market
7.2.1 UK Automated and Closed Cell Therapy Processing Systems Market by Type
7.2.2 UK Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.2.3 UK Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3 France Automated and Closed Cell Therapy Processing Systems Market
7.3.1 France Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.2 France Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.3 France Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3.4 Russia Automated and Closed Cell Therapy Processing Systems Market
7.3.5 Russia Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.6 Russia Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.7 Russia Automated and Closed Cell Therapy Processing Systems Market by Scale
7.4 Spain Automated and Closed Cell Therapy Processing Systems Market
7.4.1 Spain Automated and Closed Cell Therapy Processing Systems Market by Type
7.4.2 Spain Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.4.3 Spain Automated and Closed Cell Therapy Processing Systems Market by Scale
7.5 Italy Automated and Closed Cell Therapy Processing Systems Market
7.5.1 Italy Automated and Closed Cell Therapy Processing Systems Market by Type
7.5.2 Italy Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.5.3 Italy Automated and Closed Cell Therapy Processing Systems Market by Scale
7.6 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market
7.6.1 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Type
7.6.2 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.6.3 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Scale
Chapter 8. Company Profiles
8.1 Lonza Group AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Terumo Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Cytiva (Danaher Corporation)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Miltenyi Biotech B.V. & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Product Launches and Product Expansions:
8.5.2.3 Acquisition and Mergers:
8.6 ThermoGenesis Holdings, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Cellares, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Biospherix ltd.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Sartorius AG
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.1 Fresenius SE & Co. KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
TABLE 1 Europe Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 2 Europe Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Automated And Closed Cell Therapy Processing Systems Market
TABLE 4 Product Launches And Product Expansions– Automated And Closed Cell Therapy Processing Systems Market
TABLE 5 Acquisition and Mergers– Automated And Closed Cell Therapy Processing Systems Market
TABLE 6 Europe Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 7 Europe Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 8 Europe Non-Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 9 Europe Non-Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 10 Europe Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 11 Europe Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 12 Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 13 Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 14 Europe Expansion Market by Country, 2017 - 2020, USD Million
TABLE 15 Europe Expansion Market by Country, 2021 - 2027, USD Million
TABLE 16 Europe Separation Market by Country, 2017 - 2020, USD Million
TABLE 17 Europe Separation Market by Country, 2021 - 2027, USD Million
TABLE 18 Europe Apheresis Market by Country, 2017 - 2020, USD Million
TABLE 19 Europe Apheresis Market by Country, 2021 - 2027, USD Million
TABLE 20 Europe Cryopreservation Market by Country, 2017 - 2020, USD Million
TABLE 21 Europe Cryopreservation Market by Country, 2021 - 2027, USD Million
TABLE 22 Europe Fill- Finish Market by Country, 2017 - 2020, USD Million
TABLE 23 Europe Fill- Finish Market by Country, 2021 - 2027, USD Million
TABLE 24 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 25 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 26 Europe Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 27 Europe Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 28 Europe Pre-commercial/ R&D Scale Market by Country, 2017 - 2020, USD Million
TABLE 29 Europe Pre-commercial/ R&D Scale Market by Country, 2021 - 2027, USD Million
TABLE 30 Europe Commercial Scale Market by Country, 2017 - 2020, USD Million
TABLE 31 Europe Commercial Scale Market by Country, 2021 - 2027, USD Million
TABLE 32 Europe Automated and Closed Cell Therapy Processing Systems Market by Country, 2017 - 2020, USD Million
TABLE 33 Europe Automated and Closed Cell Therapy Processing Systems Market by Country, 2021 - 2027, USD Million
TABLE 34 Germany Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 35 Germany Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 36 Germany Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 37 Germany Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 38 Germany Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 39 Germany Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 40 Germany Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 41 Germany Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 42 UK Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 43 UK Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 44 UK Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 45 UK Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 46 UK Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 47 UK Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 48 UK Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 49 UK Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 50 France Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 51 France Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 52 France Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 53 France Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 54 France Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 55 France Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 56 France Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 57 France Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 58 Russia Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 59 Russia Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 60 Russia Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 61 Russia Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 62 Russia Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 63 Russia Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 64 Russia Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 65 Russia Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 66 Spain Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 67 Spain Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 68 Spain Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 69 Spain Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 70 Spain Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 71 Spain Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 72 Spain Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 73 Spain Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 74 Italy Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 75 Italy Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 76 Italy Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 77 Italy Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 78 Italy Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 79 Italy Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 80 Italy Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 81 Italy Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 82 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 83 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 84 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 85 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 86 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 87 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 88 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 89 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 90 Key Information – Lonza Group AG
TABLE 91 Key Information – Terumo Corporation
TABLE 92 Key Information – Cytiva
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 95 Key information – THERMOGENESIS HOLDINGS, INC.
TABLE 96 Key information – Cellares, Inc.
TABLE 97 Key information – Biospherix ltd.
TABLE 98 Key Information – Sartorius AG
TABLE 99 key information – Fresenius SE & Co. KGaA
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
FIG 5 Recent strategies and developments: Lonza Group AG
FIG 6 Recent strategies and developments: Terumo Corporation
FIG 7 Recent strategies and developments: thermo fisher scientific, inc.
FIG 8 Swot analysis: thermo fisher scientific, inc.
FIG 9 Recent strategies and developments: Miltenyi Biotec B.V. & Co. KG
FIG 10 Recent strategies and developments: Sartorius AG